In the molecular landscape of LUADs, a mutation in the Kirsten rat sarcoma viral oncogene homolog (KRAS) gene is present in 30% of cases, making it the most frequent oncogenic driver mutation in this cancer type [8]. The gene discussed is KRAS; the disease is cancer.